What are the implications of having LDL below the normal range?

While high LDL cholesterol is a well-known cardiovascular risk, very low LDL levels below 40 mg/dL can indicate underlying health issues like hyperthyroidism, liver disease, or malnutrition. Most people with low LDL are healthy, but persistent levels warrant investigation to rule out conditions affecting cholesterol metabolism.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding LDL Cholesterol and Normal Ranges

Low-density lipoprotein (LDL) cholesterol, often called "bad cholesterol," typically gets attention for being too high. However, having LDL levels below the normal range can also raise important health questions. While less common than elevated LDL, abnormally low levels deserve attention as they may signal underlying health conditions or nutritional deficiencies.

The standard reference range for LDL cholesterol is typically 0-99 mg/dL for optimal levels, with less than 100 mg/dL considered desirable for most adults. However, when LDL drops below 40 mg/dL, it enters territory that may warrant further investigation. Some laboratories consider anything below 50 mg/dL as potentially low, though this varies based on individual risk factors and overall health status.

What Constitutes Low LDL?

Medical professionals generally consider LDL cholesterol low when it falls below 40 mg/dL, though some use 50 mg/dL as the threshold. Unlike high LDL, which has clear cardiovascular risks, low LDL presents a more nuanced picture. Some people naturally have lower LDL levels without any health issues, particularly those with excellent metabolic health or specific genetic variations.

LDL Cholesterol Levels and Clinical Significance

LDL Level (mg/dL)CategoryHealth ImplicationsRecommended Action
Below 40<40 mg/dLVery LowMay indicate underlying health issues, malnutrition, or genetic factorsInvestigate underlying causes, comprehensive health evaluation
40-7040-70 mg/dLLowGenerally safe for most; may be beneficial for high cardiovascular risk patientsMonitor regularly, assess for symptoms
70-9970-99 mg/dLOptimalIdeal range for most adults without risk factorsMaintain through healthy lifestyle
100-129100-129 mg/dLNear OptimalAcceptable for healthy adults; borderline for those with risk factorsLifestyle modifications recommended
Above 130>130 mg/dLHighIncreased cardiovascular disease riskMedical evaluation, possible treatment

LDL levels should be interpreted alongside other cardiovascular risk factors and overall health status.

Understanding your complete lipid profile provides better context than looking at LDL alone. Regular monitoring through comprehensive testing helps establish your baseline and identify any concerning trends.

Common Causes of Low LDL Cholesterol

Medical Conditions

Several health conditions can cause LDL levels to drop below normal ranges:

  • Hyperthyroidism: An overactive thyroid increases metabolism, potentially lowering cholesterol levels
  • Liver disease: Since the liver produces cholesterol, conditions like cirrhosis or hepatitis can reduce production
  • Malabsorption disorders: Conditions affecting nutrient absorption, such as celiac disease or Crohn's disease
  • Cancer: Certain cancers, particularly blood cancers, can affect cholesterol metabolism
  • Chronic infections or inflammatory conditions: These can alter lipid metabolism
  • Genetic conditions: Rare disorders like abetalipoproteinemia or hypobetalipoproteinemia

Lifestyle and Dietary Factors

Your daily habits and nutritional intake significantly influence LDL levels:

  • Extremely low-fat diets: Severe restriction of dietary fats can lower cholesterol production
  • Malnutrition or eating disorders: Inadequate caloric intake affects cholesterol synthesis
  • Intense endurance training: Some elite athletes show lower LDL levels
  • Certain medications: Statins (when overly effective), thyroid medications, or some antibiotics
  • Vegan or vegetarian diets: Plant-based diets typically result in lower cholesterol levels

Health Implications of Low LDL

While high LDL clearly increases cardiovascular disease risk, the implications of low LDL are more complex. Research suggests that very low LDL levels may be associated with certain health concerns, though the relationship isn't always causal.

Potential Health Concerns

Studies have identified several potential issues associated with very low LDL cholesterol:

  • Hemorrhagic stroke: Some research suggests increased risk with LDL below 70 mg/dL, though this remains controversial
  • Mental health effects: Associations with depression, anxiety, and mood changes have been reported
  • Cancer risk: Some studies show correlations, though low LDL may be a result rather than cause
  • Hormonal imbalances: Cholesterol is essential for hormone production
  • Vitamin deficiencies: Particularly fat-soluble vitamins (A, D, E, K) that require lipids for absorption

When Low LDL May Be Beneficial

Not all low LDL is problematic. For individuals with significant cardiovascular disease risk or history, achieving very low LDL through medication or lifestyle changes often provides net benefit. The key is understanding whether low levels result from intentional intervention or underlying pathology.

Symptoms Associated with Low LDL

Low LDL itself rarely causes direct symptoms. However, the underlying conditions causing low LDL or the consequences of chronically low levels may produce noticeable effects:

  • Fatigue and weakness
  • Difficulty concentrating or brain fog
  • Mood changes, including depression or anxiety
  • Digestive issues (if related to malabsorption)
  • Changes in appetite
  • Unexplained weight loss
  • Skin or hair changes

These symptoms often relate more to the underlying cause than the low LDL itself. Comprehensive testing can help identify whether other biomarkers are also affected.

Diagnostic Approach and Testing

Initial Evaluation

When low LDL is detected, healthcare providers typically recommend:

  1. Repeat lipid panel to confirm the finding
  2. Complete metabolic panel to assess liver and kidney function
  3. Thyroid function tests (TSH, Free T3, Free T4)
  4. Complete blood count to rule out blood disorders
  5. Nutritional assessment, including vitamin levels
  6. Review of medications and supplements

Advanced Testing Considerations

Depending on initial findings, additional tests may include:

  • Apolipoprotein B (ApoB) levels for better cardiovascular risk assessment
  • Inflammatory markers like high-sensitivity C-reactive protein (hs-CRP)
  • Hormone panels to evaluate endocrine function
  • Genetic testing for familial hypobetalipoproteinemia
  • Imaging studies if organ dysfunction is suspected

Management Strategies for Low LDL

Addressing Underlying Causes

Treatment focuses on identifying and managing the root cause:

  • Thyroid disorders: Appropriate hormone replacement therapy
  • Liver disease: Specialized treatment based on specific condition
  • Malabsorption: Dietary modifications and possible supplementation
  • Medication-related: Dosage adjustment or alternative medications
  • Nutritional deficiencies: Targeted supplementation and dietary changes

Dietary Modifications

If low LDL results from dietary factors, consider:

  • Increasing healthy fat intake from sources like avocados, nuts, and olive oil
  • Ensuring adequate protein consumption
  • Adding nutrient-dense foods to support overall health
  • Working with a registered dietitian for personalized guidance
  • Avoiding extreme dietary restrictions unless medically necessary

Monitoring and Follow-up Care

Regular monitoring helps track progress and ensure interventions are effective. Most healthcare providers recommend retesting lipid panels every 3-6 months initially, then annually once levels stabilize. This frequency may increase if you're actively addressing an underlying condition or making significant lifestyle changes.

Beyond lipid panels, monitoring should include assessment of symptoms, nutritional status, and any conditions contributing to low LDL. Keeping detailed records of dietary changes, medications, and how you feel can help your healthcare team optimize your treatment plan.

The Bottom Line on Low LDL Cholesterol

While less common than high LDL, abnormally low levels deserve attention and investigation. For most people, low LDL isn't immediately dangerous, but it may signal underlying health issues requiring treatment. The key is understanding whether your low levels result from healthy lifestyle choices, medical interventions, or undiagnosed conditions.

Work with your healthcare provider to determine the cause of low LDL and develop an appropriate management plan. Regular monitoring, addressing underlying conditions, and maintaining overall nutritional health typically lead to the best outcomes. Remember that cholesterol management is just one aspect of cardiovascular and overall health—a comprehensive approach considering all risk factors provides the most benefit.

Frequently Asked Questions

How can I test my LDL cholesterol at home?

You can test your LDL cholesterol at home with [SiPhox Health's Heart & Metabolic Program](siphoxhealth.com/pricing/easydraw-heart-and-metabolic-program), which includes LDL cholesterol testing along with other essential cardiovascular biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home.

Is low LDL cholesterol dangerous?

Low LDL cholesterol below 40 mg/dL can be concerning, though many people with low levels are perfectly healthy. The danger depends on the underlying cause—whether it's due to a medical condition, malnutrition, or simply genetics. Always consult with a healthcare provider to determine if your low LDL requires intervention.

What foods can help raise LDL cholesterol if it's too low?

To naturally increase LDL levels, focus on incorporating healthy fats like avocados, nuts, seeds, olive oil, and fatty fish. Eggs, full-fat dairy products, and lean meats can also help. Avoid trans fats and processed foods—the goal is raising cholesterol through nutritious whole foods.

Can medications cause low LDL cholesterol?

Yes, several medications can lower LDL cholesterol, including statins (especially at high doses), thyroid hormones, certain antibiotics, and some psychiatric medications. If you suspect your medication is causing very low LDL, discuss dosage adjustments with your healthcare provider rather than stopping treatment on your own.

References

  1. Ravnskov, U., Diamond, D. M., Hama, R., Hamazaki, T., Hammarskjöld, B., Hynes, N., ... & Sundberg, R. (2016). Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ open, 6(6), e010401.[Link][DOI]
  2. Benn, M., Tybjærg-Hansen, A., Stender, S., Frikke-Schmidt, R., & Nordestgaard, B. G. (2011). Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study. Journal of the National Cancer Institute, 103(6), 508-519.[Link][PubMed][DOI]
  3. Nago, N., Ishikawa, S., Goto, T., & Kayaba, K. (2011). Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School Cohort Study. Journal of epidemiology, 21(1), 67-74.[Link][PubMed][DOI]
  4. Olsson, A. G., Angelin, B., Assmann, G., Binder, C. J., Björkhem, I., Cedazo-Minguez, A., ... & Yvan-Charvet, L. (2017). Can LDL cholesterol be too low? Possible risks of extremely low levels. Journal of internal medicine, 281(6), 534-553.[Link][PubMed][DOI]
  5. Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., ... & Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation, 139(25), e1082-e1143.[Link][PubMed][DOI]
  6. Huang, Y. Q., Liu, X. C., Lo, K., Liu, L., Yu, Y. L., Chen, C. L., ... & Feng, Y. Q. (2020). The U shaped relationship between low-density lipoprotein cholesterol and all-cause mortality in patients with hypertension. Medicine, 99(28), e21078.[Link][PubMed][DOI]

Frequently Asked Questions

How can I test my LDL cholesterol at home?

You can test your LDL cholesterol at home with SiPhox Health's Heart & Metabolic Program, which includes LDL cholesterol testing along with other essential cardiovascular biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home.

Is low LDL cholesterol dangerous?

Low LDL cholesterol below 40 mg/dL can be concerning, though many people with low levels are perfectly healthy. The danger depends on the underlying cause—whether it's due to a medical condition, malnutrition, or simply genetics. Always consult with a healthcare provider to determine if your low LDL requires intervention.

What foods can help raise LDL cholesterol if it's too low?

To naturally increase LDL levels, focus on incorporating healthy fats like avocados, nuts, seeds, olive oil, and fatty fish. Eggs, full-fat dairy products, and lean meats can also help. Avoid trans fats and processed foods—the goal is raising cholesterol through nutritious whole foods.

Can medications cause low LDL cholesterol?

Yes, several medications can lower LDL cholesterol, including statins (especially at high doses), thyroid hormones, certain antibiotics, and some psychiatric medications. If you suspect your medication is causing very low LDL, discuss dosage adjustments with your healthcare provider rather than stopping treatment on your own.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details